Group leaders

Notre service exerce une importante activité de recherche incluant des études épidémiologiques et cliniques, des activités de recherche fondamentale et translationnelle allant de l'analyse des mécanismes moléculaires et cellulaires de la réponse immunitaire à l'étude des pathogènes afin de développer de nouvelles stratégies pour le diagnostic, la prévention et le traitement des maladies infectieuses.

Ses axes de recherche portent sur:

MIF, a central regulator of innate immune responses
Host defenses, epigenetic and trained immunity
Enhancing sepsis management
Fecal Microbiota Transplantation Versus Vancomycin or Fidaxomicin in Clostridioides difficile Infection First Episode and First Recurrence: A Randomized Controlled, Open-label Multicenter Phase III Clinical Trial
NCCR Microbiome
Stability of structure and function of lyophilized gastro-resistant formulation for fecal microbiota transplantation compared to capsules and fresh stools
Risk assessment of Dientamoeba fragilis transmission through fecal microbiota transplantation and its consequences in recipients (FMT-fragilis)
Associated Research projects
Covid-19 and other infectious complications
Vaccination in immunocompromised patients
CMV after organ transplantation
HIV Diagnosis
Adherence and pharmacological studies
Cognitive disorders among people living with HIV
Sepsis project
Antimicrobial tolerance
Infective endocarditis
Bacteraemia/ candidaemia
Antimicrobial resistance
Antibiotic Stewardship
Healthcare-Associated Infections (HAIs)
Mechanisms of antifungal resistance in pathogenic fungi
Molecular and genomic epidemiology of nosocomial infections
Functional Immunogenetics of Viral Infections
MINCO, a Cohort & Biobank for Infections in Onco-Hematological Patients
Host Genetics in Solid Organ Transplant Recipients
Immunogenetics of Fungal Infections
The molecular basis of HIV-specific T cell dysfunction
Immunological consequences of HIV reservoir activity in people on antiretroviral therapy